Cholesterol levels after 3 days of high-dose simvastatin in patients at moderate to high risk for coronary events-Reference-Cited by-同舟云学术

Cholesterol levels after 3 days of high-dose simvastatin in patients at moderate to high risk for coronary events

Published:2005-05 Issue:1 Volume:101 Page:111-114
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Michelena Hector I.,Osorio Luis A.,Citkowitz Elena

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia;Shepherd;N. Engl. J. Med.,1995

3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels;Sacks;N. Engl. J. Med.,1996

4. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels;N. Engl. J. Med.,1998

5. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS;Downs;JAMA,1998

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid effects of different lipid-lowering drugs on PCSK9 in humans;Clinical Lipidology;2013-10-01

2. Immediate effect of intensive atorvastatin therapy on lipid parameters in patients with acute coronary syndrome;Lipids in Health and Disease;2010-07-14

3. Rapid response to lipids profile and leukocyte gene expression after rosuvastatin administration in Chinese healthy volunteers;Chinese Medical Journal;2008-07

4. Immediate effect of fluvastatin on lipid levels in acute coronary syndrome;Molecular and Cellular Biochemistry;2007-07-25

5. Cholesterol Levels After 3 Days of High-Dose Simvastatin in Patients at Moderate to High Risk for Coronary Events;Yearbook of Endocrinology;2006-01